Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

NCT00665743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis

Interventions

DRUG: PN400
DRUG: naproxen
DRUG: naproxen

Sponsor

POZEN